Figure 1.

Levels of CK‐MB, MYO, ultra‐TnI, and NT‐proBNP of the three patients with COVID‐19 groups were compared and analyzed. According to the relevant diagnostic criteria, patients were divided into three groups: mild (n = 198), severe (n = 60), and critical (n = 15). CK‐MB, creatine kinase isoenzyme‐MB; MYO, myohemoglobin; NT‐proBNP, N‐terminal pro‐brain natriuretic peptide; COVID, coronavirus disease. ***P < .001